GE HealthCare Technologies
Stock Forecast, Prediction & Price Target
GE HealthCare Technologies (GEHC) stock Price Target by analysts
$92
Potential upside: 24.15%
GE HealthCare Technologies price prediction
What is GE HealthCare Technologies stock analysts` prediction?
GE HealthCare Technologies stock forecast: Based on 4 Wall Street analysts` predicted price targets for GE HealthCare Technologies in the last 3 months, the avarage price target is $92, with a high forecast of $NaN. The average price target represents a 24.15% change from the last price of $74.1.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
GE HealthCare Technologies stock Price Target by analysts
Full breakdown of analysts given GE HealthCare Technologies price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Jason Bednar Piper Sandler | 0% 0/2 | 10 months ago | $97 30.90% upside | $82.08 | StreetInsider | Previous targets (1) |
Graham Doyle UBS | 50% 1/2 | 12 months ago | $74 -0.13% downside | $93.01 | TheFly | Previous targets (1) |
Craig Bijou Bank of America Securities | 0% 0/1 | 12 months ago | $97 30.90% upside | $90.62 | TheFly | Previous targets (0) |
Ryan Zimmerman BTIG | 0% 0/1 | 12 months ago | $100 34.95% upside | $86.79 | TheFly | Previous targets (0) |
David Roman Goldman Sachs | 0% 0/1 | over 1 year ago | $87 17.40% upside | $78.45 | TheFly | Previous targets (0) |
Jason Bednar Piper Sandler | 0% 0/2 | over 1 year ago | $92 24.15% upside | $81.5 | StreetInsider | Previous targets (1) |
Anthony Petrone Mizuho Securities | 0% 0/2 | over 1 year ago | $105 41.70% upside | $77.74 | StreetInsider | Previous targets (1) |
Vijay Kumar Evercore ISI | 0% 0/1 | over 1 year ago | $96 29.55% upside | $76.24 | StreetInsider | Previous targets (0) |
Anthony Petrone Mizuho Securities | 0% 0/2 | over 1 year ago | $110 48.44% upside | $85.39 | StreetInsider | Previous targets (1) |
David Toung Argus Research | 0% 0/1 | over 1 year ago | $110 48.44% upside | $90.91 | StreetInsider | Previous targets (0) |
Graham Doyle UBS | 50% 1/2 | over 1 year ago | $88 18.75% upside | $83.17 | StreetInsider | Previous targets (1) |
Patrick Wood Morgan Stanley | 100% 1/1 | about 2 years ago | $76 2.56% upside | $77.17 | Benzinga | Previous targets (0) |
Suraj Kalia Oppenheimer | 0% 0/1 | over 2 years ago | $97 30.90% upside | $77 | Benzinga | Previous targets (0) |
GE HealthCare Technologies Financial Estimates
GE HealthCare Technologies Revenue Estimates
GE HealthCare Technologies EBITDA Estimates
GE HealthCare Technologies Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $17.58B N/A | $18.34B 4.29% | $19.55B 6.60% | Avg: $21.15B Low: $20.99B High: $21.32B avg. 8.22% | Avg: $22.28B Low: $22.07B High: $22.53B avg. 5.32% | Avg: $24.24B Low: $24.01B High: $24.51B avg. 8.78% | Avg: $26.45B Low: $26.20B High: $26.75B avg. 9.11% |
Net Income
% change YoY
| $2.24B N/A | $1.91B -14.73% | $1.56B -18.16% | Avg: $2.11B Low: $2.00B High: $2.23B avg. 35.13% | Avg: $2.35B Low: $2.17B High: $2.47B avg. 11.35% | Avg: $2.85B Low: $2.81B High: $2.89B avg. 20.83% | Avg: $3.32B Low: $3.28B High: $3.36B avg. 16.46% |
EBITDA
% change YoY
| $3.54B N/A | $3.22B -8.98% | $3.54B 10.14% | Avg: $3.91B Low: $3.88B High: $3.94B avg. 10.38% | Avg: $4.12B Low: $4.08B High: $4.17B avg. 5.32% | Avg: $4.48B Low: $4.44B High: $4.53B avg. 8.78% | Avg: $4.89B Low: $4.85B High: $4.95B avg. 9.11% |
EPS
% change YoY
| $4.9 N/A | $4.22 -13.87% | $3.04 -27.96% | Avg: $4.61 Low: $4.38 High: $4.87 avg. 51.53% | Avg: $5.17 Low: $4.75 High: $5.4 avg. 12.32% | Avg: $6.23 Low: $6.15 High: $6.32 avg. 20.30% | Avg: $7.25 Low: $7.16 High: $7.36 avg. 16.46% |
Operating Expenses
% change YoY
| $4.37B N/A | $4.65B 6.34% | $5.48B 17.82% | Avg: $4.33B Low: $4.30B High: $4.36B avg. -21.01% | Avg: $4.56B Low: $4.52B High: $4.61B avg. 5.32% | Avg: $4.96B Low: $4.91B High: $5.02B avg. 8.78% | Avg: $5.41B Low: $5.36B High: $5.47B avg. 9.11% |
FAQ
What is GE HealthCare Technologies stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 20.94% in 2025-2028.
We have gathered data from 10 analysts. Their low estimate is 2.00B, average is 2.11B and high is 2.23B.
What is GE HealthCare Technologies stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 7.86% in 2025-2028.
We have gathered data from 11 analysts. Their low revenue estimate is $20.99B, average is $21.15B and high is $21.32B.
What is GE HealthCare Technologies stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 25.15% in 2025-2028.
We have gathered data from 10 analysts. Their low earnings per share estimate is $4.38, average is $4.61 and high is $4.87.
What is the best performing analyst?
In the last twelve months 4 analysts have been covering GE HealthCare Technologies stock. The most successful analyst is Jason Bednar.